Previous Close | 53.26 |
Open | 53.84 |
Bid | 50.48 x 800 |
Ask | 59.50 x 800 |
Day's Range | 52.73 - 54.13 |
52 Week Range | 49.15 - 63.83 |
Volume | |
Avg. Volume | 279,303 |
Market Cap | 2.706B |
Beta (5Y Monthly) | 0.65 |
PE Ratio (TTM) | 15.25 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Sep 27, 2018 |
1y Target Est | N/A |
Company Exceeds Full-Year Earnings Outlook for Revenue, EPS, and Cash FlowRevenue of $266.9 Million in Q4 and $1,086.8 Million for Full-Year Fiscal 2022, up 12.3% and 15.2% versus Prior Year, respectivelyAdjusted Diluted EPS of $4.06 for Fiscal 2022, up 25.3% versus Prior YearNet Cash Provided by Operating Activities of $259.9 Million and Record Non-GAAP Free Cash Flow of $253.7 Million in Full-Year Fiscal 2022Initial Full-Year Fiscal 2023 Revenue Outlook of Approximately 3% to 4%Board of Direct
TARRYTOWN, N.Y., April 14, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2022 fourth quarter and year-end earnings release on Thursday, May 5, 2022 after the market close. The following morning, May 6, at 8:30 a.m. ET, the Company will host a conference call to discuss the results as well as for a discussion into the Company’s leading business attributes. To participate via phone listeners calling from the U.S. and Canada may
Revenue of $274.5 Million in Q3, up 14.9% versus Prior Year, up 8.8% on an Organic BasisDiluted EPS of $0.99 in Q3, up 22.2% versus Prior YearNon-GAAP Free Cash Flow of $64.1 Million for Third Quarter Fiscal 2022, up Double-digits versus Prior YearRaising Full-Year Fiscal 2022 Outlook TARRYTOWN, N.Y., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter ended December 31, 2021. “We are pleased with our third quarter